KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Long-Term Debt Repayments (2016 - 2025)

Gilead Sciences' Long-Term Debt Repayments history spans 17 years, with the latest figure at $8.0 million for Q4 2025.

  • For Q4 2025, Long-Term Debt Repayments rose 14.29% year-over-year to $8.0 million; the TTM value through Dec 2025 reached $1.8 billion, down 9.24%, while the annual FY2025 figure was $1.8 billion, 9.24% down from the prior year.
  • Long-Term Debt Repayments reached $8.0 million in Q4 2025 per GILD's latest filing, down from $9.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $2.5 billion in Q3 2021 to a low of $7.0 million in Q4 2024.
  • Average Long-Term Debt Repayments over 5 years is $942.9 million, with a median of $1.0 billion recorded in 2021.
  • Peak YoY movement for Long-Term Debt Repayments: skyrocketed 150.0% in 2021, then plummeted 99.51% in 2025.
  • A 5-year view of Long-Term Debt Repayments shows it stood at $1.0 billion in 2021, then changed by 0.0% to $1.0 billion in 2022, then surged by 125.0% to $2.2 billion in 2023, then crashed by 99.69% to $7.0 million in 2024, then grew by 14.29% to $8.0 million in 2025.
  • Per Business Quant, the three most recent readings for GILD's Long-Term Debt Repayments are $8.0 million (Q4 2025), $9.0 million (Q3 2025), and $9.0 million (Q2 2025).